3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Leukemia
40
Lymphoma
39
Melanoma
27
Leukemia, Lymphocytic, Chronic, B-Cell
27
Lymphoma, Non-Hodgkin
24
Lymphoma, Follicular
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Breast Neoplasms
21
Lymphoma, Large B-Cell, Diffuse
20
Lymphoma, Mantle-Cell
19
Myelodysplastic Syndromes
17
Neuroblastoma
16
Lymphoma, Large-Cell, Immunoblastic
16
Hodgkin Disease
16
Multiple Myeloma
15
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Acute
15
Burkitt Lymphoma
15
Lymphoma, B-Cell, Marginal Zone
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
14
Prostatic Neoplasms
13
Neoplasm Metastasis
13
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
11
Neoplasms, Plasma Cell
10
Leukemia, Myeloid, Accelerated Phase
10
Glioblastoma
10
Congenital Abnormalities
10
Carcinoma, Ovarian Epithelial
9
Ovarian Neoplasms
8
Interventions
pembrolizumab
12
Radiotherapy
9
avelumab
8
Nivolumab
8
cemiplimab
4
Radiation
4
Ipilimumab
4
poly ICLC
3
atezolizumab
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Etoposide
3
Cyclophosphamide
3
talimogene laherparepvec
2
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
durvalumab
2
aldesleukin
2
Interferon-beta
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Cisplatin
2
Carboplatin
2
Biopsy
2
veliparib
1
vatalanib
1
tremelimumab
1
tocilizumab
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Merkel Cell
×
sargramostim
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled